We are live on ! Find out more
ANIP icon

ANI Pharmaceuticals
ANIP

157 hedge funds and large institutions have $379M invested in ANI Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 58 increasing their positions, 47 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more ownership

Funds ownership: 0% → 54% (+54%)

23% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 47

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5% less capital invested

Capital invested by funds: $399M → $379M (-$19.5M)

8% less funds holding

Funds holding: 170 → 157 (-13)

33% less call options, than puts

Call options by funds: $6.65M | Put options by funds: $9.9M

40% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 25

Holders
157
Holders Change
-13
Holders Change %
-7.65%
% of All Funds
3.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
58
Reduced
47
Closed
25
Calls
$6.65M
Puts
$9.9M
Net Calls
-$3.25M
Net Calls Change
-$3.46M

Top Buyers

1
PA
Perceptive Advisors
New York
+$15.6M
2
GT
Glenmede Trust
Pennsylvania
+$15.1M
3
BFA
BlackRock Fund Advisors
California
+$4.65M
4
Bank of America
Bank of America
North Carolina
+$4.12M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.66M

Top Sellers

1
CCM
Consonance Capital Management
New York
-$9.88M
2
CM
Castleark Management
Illinois
-$6.68M
3
SGAM
Smith Group Asset Management
Texas
-$3.96M
4
BIM
Bogle Investment Management
Massachusetts
-$3.7M
5
MCM
McKinley Capital Management
Alaska
-$3.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
TWMP
151
Taylor Wealth Management Partners
Massachusetts
$1K +$611 +10 New
WEC
152
Winslow Evans & Crocker
Massachusetts
$486 – – –
KLI
153
Kelman-Lazarov Inc
Tennessee
$60 – – –
CM
154
Castleark Management
Illinois
– -$6.68M -100,615 Closed
SGAM
155
Smith Group Asset Management
Texas
– -$3.96M -59,690 Closed
BIM
156
Bogle Investment Management
Massachusetts
– -$3.7M -55,705 Closed
MCM
157
McKinley Capital Management
Alaska
– -$3.46M -52,215 Closed
MOACM
158
Mutual of America Capital Management
New York
– -$1.99M -29,978 Closed
OAM
159
Oxford Asset Management
United Kingdom
– -$1.46M -21,986 Closed
DC
160
Deere & Company
Illinois
– -$1.26M -19,044 Closed
NI
161
Numeric Investors
Massachusetts
– -$1.09M -16,400 Closed
EI
162
EAM Investors
California
– -$1.06M -15,947 Closed
Citadel Advisors
163
Citadel Advisors
Florida
– -$863K -14,113 Closed
ZIM
164
Zacks Investment Management
Illinois
– -$681K -10,267 Closed
EMG
165
Ellington Management Group
Connecticut
– -$650K -9,800 Closed
RJFSA
166
Raymond James Financial Services Advisors
Florida
– -$407K -6,131 Closed
UBS AM
167
UBS AM
Illinois
– -$312K -4,700 Closed
ECM
168
Endurant Capital Management
California
– -$305K -4,600 Closed
LSERS
169
Louisiana State Employees Retirement System
Louisiana
– -$232K -3,500 Closed
OAM
170
Origin Asset Management
United Kingdom
– -$213K -3,203 Closed
DCM
171
Driehaus Capital Management
Illinois
– -$210K -3,160 Closed
State Board of Administration of Florida Retirement System
172
State Board of Administration of Florida Retirement System
Florida
– -$204K -3,071 Closed
HighTower Advisors
173
HighTower Advisors
Illinois
– -$202K -3,050 Closed
AIM
174
Acrospire Investment Management
Illinois
– -$174K -2,621 Closed
PCM
175
Prelude Capital Management
New York
– -$123K -1,858 Closed
4 5 6
7
8

ANIP Hedge Fund Activity: Q4 2016 in Review

157 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q4 2016, worth a combined $379M — down 4.9% from $399M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of ANIP and 15 opened new positions — a net loss of 10 holders — while 47 trimmed existing stakes and 58 added.

The largest buyer was Perceptive Advisors, adding an estimated $15.6M. The largest seller was Consonance Capital Management, cutting an estimated $9.88M.

  • 157 institutional investors held ANI Pharmaceuticals (ANIP) as of Q4 2016, down from 170 in Q3 2016.
  • Funds reported $379M of ANI Pharmaceuticals stock for Q4 2016, down 4.9% quarter-over-quarter.
  • 15 funds opened new ANI Pharmaceuticals positions in Q4 2016 and 25 closed out, a net change of -10 holders.
  • The largest ANI Pharmaceuticals buyer in Q4 2016 was Perceptive Advisors, an estimated $15.6M added.
  • The largest ANI Pharmaceuticals seller in Q4 2016 was Consonance Capital Management, an estimated $9.88M sold.

Based on aggregated 13F filings for Q4 2016.